Works matching DE "ROTIGOTINE"

Results: 135

Author Correction: Computational polymorph screening reveals late-appearing and poorly-soluble form of rotigotine.

Published in:

2019

By:

Mortazavi, Majid;
Hoja, Johannes;
Aerts, Luc;
Quéré, Luc;
van de Streek, Jacco;
Neumann, Marcus A.;
Tkatchenko, Alexandre

Publication type:

Correction Notice

Computational polymorph screening reveals late-appearing and poorly-soluble form of rotigotine.

Published in:

Communications Chemistry, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1038/s42004-019-0171-y

By:

Mortazavi, Majid;
Hoja, Johannes;
Aerts, Luc;
Quéré, Luc;
van de Streek, Jacco;
Neumann, Marcus A.;
Tkatchenko, Alexandre

Publication type:

Article

Duration of step initiation predicts freezing in Parkinson's disease.

Published in:

Acta Neurologica Scandinavica, 2015, v. 132, n. 2, p. 105, doi. 10.1111/ane.12361

By:

Chong, R. K.;
Lee, K.‐H.;
Morgan, J.;
Wakade, C.

Publication type:

Article

Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.

Published in:

Acta Neurologica Scandinavica, 2015, v. 132, n. 2, p. 79, doi. 10.1111/ane.12375

By:

Domellöf, M. E.;
Ekman, U.;
Forsgren, L.;
Elgh, E.

Publication type:

Article

The EIF4G1 gene and Parkinson's disease.

Published in:

Acta Neurologica Scandinavica, 2015, v. 132, n. 2, p. 73, doi. 10.1111/ane.12397

By:

Deng, H.;
Wu, Y.;
Jankovic, J.

Publication type:

Article

Efectos de la rotigotina sobre la sintomatología, calidad de vida e higiene de sueño en el síndrome de piernas inquietas en hemodiálisis.

Published in:

Nefrologia, 2018, v. 38, n. 1, p. 79, doi. 10.1016/j.nefro.2017.03.023

By:

Esteve, Vicent;
Carneiro, Jose;
Salazar, Gabriel;
Pou, Mónica;
Tapia, Irati;
Fulquet, Miquel;
Duarte, Verónica;
Saurina, Anna;
Moreno, Fátima;
de Arellano, Manel Ramírez

Publication type:

Article

Baicalein Prevents 6-Hydroxydopamine-Induced Mitochondrial Dysfunction in SH-SY5Y Cells via Inhibition of Mitochondrial Oxidation and Up-Regulation of DJ-1 Protein Expression.

Published in:

Molecules, 2013, v. 18, n. 12, p. 14726, doi. 10.3390/molecules181214726

By:

Yue-Hua Wang;
Hai-Tao Yu;
Xiao-Ping Pu;
Guan-Hua Du

Publication type:

Article

Stunning discovery involving the brain-inspiring new questions and treatment for Parkinson's, Alzheimer's, dementia, and other neurological disorders: A unifying hypothesis?

Published in:

2018

By:

Feld, Leonard J.

Publication type:

Letter to the Editor

Rotigotine.

Published in:

Formulary, 2007, v. 42, n. 11, p. 633

By:

Talati, Ripple;
White, C. Michael;
Coleman, Craig I.

Publication type:

Article

The Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson's Disease Owing Genetic and Anatomical Specificity.

Published in:

Frontiers in Cellular Neuroscience, 2017, v. 11, p. 1, doi. 10.3389/fncel.2017.00102

By:

Gambardella, Stefano;
Ferese, Rosangela;
Biagioni, Francesca;
Busceti, Carla L.;
Campopiano, Rosa;
Griguoli, Anna M. P.;
Limanaqi, Fiona;
Novelli, Giuseppe;
Storto, Marianna;
Fornai, Francesco

Publication type:

Article

Commentary: Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.

Published in:

2017

By:

Jin-Sung Park;
Koentjoro, Brianada;
Sue, Carolyn M.

Publication type:

Editorial

Granulocyte-Colony Stimulating Factor Prevents Motor Dysfunction and Histological Damages In A Rat Model Of Parkinson's Disease.

Published in:

Egyptian Journal of Hospital Medicine, 2017, v. 69, n. 1, p. 1628, doi. 10.12816/0040111

By:

Azmy, Mariama S.;
Menze, Esther T.;
El-Naga, Reem N.;
Tadros, Mariane G.

Publication type:

Article

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

Published in:

Annals of Neurology, 2011, v. 69, n. 5, p. 778, doi. 10.1002/ana.22321

By:

Elbaz, Alexis;
Ross, Owen A.;
Ioannidis, John P. A.;
Soto-Ortolaza, Alexandra I.;
Moisan, Frédéric;
Aasly, Jan;
Annesi, Grazia;
Bozi, Maria;
Brighina, Laura;
Chartier-Harlin, Marie-Christine;
Destée, Alain;
Ferrarese, Carlo;
Ferraris, Alessandro;
Gibson, J. Mark;
Gispert, Suzana;
Hadjigeorgiou, Georgios M.;
Jasinska-Myga, Barbara;
Klein, Christine;
Krüger, Rejko;
Lambert, Jean-Charles

Publication type:

Article

Dual pathology of corticobasal degeneration and Parkinson's disease in a patient with clinical features of progressive supranuclear palsy.

Published in:

Neurology India, 2011, v. 59, n. 6, p. 887, doi. 10.4103/0028-3886.91371

By:

Mooney, Tomin;
Tampiyappa, Anthony;
Robertson, Thomas;
Grimley, Rohan;
Burke, Chris;
Ng, Kenneth;
Patrikios, Peter

Publication type:

Article

Transdermal Rotigotine: A Clinically Innovative Dopamine-Receptor Agonist for the Management of Parkinson's Disease.

Published in:

Pharmacotherapy, 2009, v. 29, n. 12, p. 1452, doi. 10.1592/phco.29.12.1452

By:

Chen, Jack J.;
Swope, David M.;
Dashtipour, Khashayar;
Lyons, Kelly E.

Publication type:

Article

Dopamine receptor agonist rotigotine-loaded microspheres ameliorates sexual function deteriorated by fluoxetine in depression rats.

Published in:

ASN Neuro, 2021, p. 1, doi. 10.1177/17590914211052862

By:

Wang, Wenqian;
Zhang, Ce;
Fan, Yiqian;
Yue, Shumin;
Yang, Yunqi;
Liu, Rongxia;
Zhang, Leiming;
Wang, Tian;
Fu, Fenghua

Publication type:

Article

Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Published in:

Neurophysiology, 2016, v. 48, n. 3, p. 176, doi. 10.1007/s11062-016-9586-6

By:

Mirzaie, M.;
Khalili, M.;
Kiasalari, Z.;
Roghani, M.

Publication type:

Article

Allergic contact dermatitis caused by rotigotine in a transdermal therapeutic system.

Published in:

Contact Dermatitis (01051873), 2016, v. 75, n. 2, p. 121, doi. 10.1111/cod.12584

By:

Raison‐Peyron, Nadia;
Guillot, Bernard

Publication type:

Article

A case of cluster headache treated with rotigotine: Clinical and neurophysiological correlates.

Published in:

2013

By:

Di Lorenzo, Cherubino;
Coppola, Gianluca;
Pierelli, Francesco

Publication type:

Case Study

Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa.

Published in:

Journal of Clinical Pharmacology, 2009, v. 49, n. 9, p. 1047, doi. 10.1177/0091270009338481

By:

Braun, Marina;
Cawello, Willi;
Andreas, Jens-Otto;
Boekens, Hilmar;
Horstmann, Rolf

Publication type:

Article

Rotigotine for the treatment of Parkinson's disease.

Published in:

Expert Review of Neurotherapeutics, 2006, v. 6, n. 9, p. 1275, doi. 10.1586/14737175.6.9.1275

By:

Morgan, John C.;
Sethi, Kapil D.

Publication type:

Article

Assessment of striatal & postural deformities in patients with Parkinson's disease.

Published in:

Indian Journal of Medical Research, 2016, v. 144, n. 5, p. 682, doi. 10.4103/ijmr.IJMR_502_15

By:

Pandey, Sanjay;
Kumar, Hitesh

Publication type:

Article

The direct analysis of drug distribution of rotigotine-loaded microspheres from tissue sections by LESA coupled with tandem mass spectrometry.

Published in:

Analytical & Bioanalytical Chemistry, 2017, v. 409, n. 22, p. 5217, doi. 10.1007/s00216-017-0440-5

By:

Xu, Li-Xiao;
Wang, Tian-Tian;
Geng, Yin-Yin;
Wang, Wen-Yan;
Li, Yin;
Duan, Xiao-Kun;
Xu, Bin;
Liu, Charles;
Liu, Wan-Hui

Publication type:

Article

Comparison of the Efficacy of Different Drugs on Non-Motor Symptoms of Parkinson’s Disease: a Network Meta-Analysis.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2018, v. 45, n. 1, p. 119, doi. 10.1159/000486252

By:

Li, Bao-Dong;
Cui, Jing-Jun;
Song, Jia;
Qi, Ce;
Ma, Pei-Feng;
Wang, Ya-Rong;
Bai, Jing

Publication type:

Article

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.

Published in:

Scientific Reports, 2013, p. 1, doi. 10.1038/srep02540

By:

Foulds, Penelope G.;
Diggle, Peter;
Douglas Mitchell, J.;
Parker, Angela;
Hasegawa, Masato;
Masuda-Suzukake, Masami;
Mann, David M. A.;
Allsop, David

Publication type:

Article

Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.

Published in:

2017

By:

Schaeffer, Eva;
Berg, Daniela

Publication type:

journal article

Rotigotine Transdermal Patch.

Published in:

CNS Drugs, 2011, v. 25, n. 8, p. 699, doi. 10.2165/11206750-000000000-00000

By:

Sanford, Mark;
Scott, Lesley J.

Publication type:

Article

Rotigotine Transdermal Patch: A Review of its Use in the Management of Parkinson's Disease.

Published in:

CNS Drugs, 2007, v. 21, n. 12, p. 1039, doi. 10.2165/00023210-200721120-00007

By:

Baldwin, Claudine M.;
Keating, Gillian M.

Publication type:

Article

The UPDRS-8: A Brief Clinical Assessment Scale for Parkinson's Disease.

Published in:

International Journal of Neuroscience, 2012, v. 122, n. 7, p. 333, doi. 10.3109/00207454.2012.657381

By:

Hauser, Robert A.;
Lyons, Kelly E.;
Pahwa, Rajesh

Publication type:

Article

Outcomes From Switching From Rotigotine Patch to Alternate Therapies in Parkinson's Disease.

Published in:

International Journal of Neuroscience, 2012, v. 122, n. 1, p. 22, doi. 10.3109/00207454.2011.617016

By:

Chitnis, Shilpa;
Jaffery, Manall;
Dewey, Richard B.

Publication type:

Article

Regulatory Action and News.

Published in:: WHO Drug Information, 2009, v. 23, n. 3, p. 219
Publication type:: Article

The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke.

Published in:

Brain: A Journal of Neurology, 2012, v. 135, n. 8, p. 2478, doi. 10.1093/brain/aws154

By:

Gorgoraptis, Nikos;
Mah, Yee-Haur;
Machner, Bjoern;
Singh-Curry, Victoria;
Malhotra, Paresh;
Hadji-Michael, Maria;
Cohen, David;
Simister, Robert;
Nair, Ajoy;
Kulinskaya, Elena;
Ward, Nick;
Greenwood, Richard;
Husain, Masud

Publication type:

Article

Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease.

Published in:

Brain: A Journal of Neurology, 2008, v. 131, n. 10, p. 2710, doi. 10.1093/brain/awn179

By:

M. Karimi;
N. Golchin;
S. D. Tabbal;
T. Hershey;
T. O. Videen;
J. Wu;
J. W. M. Usche;
F. J. Revilla;
J. M. Hartlein;
A. R. Wernle;
J. W. Mink;
J. S. Perlmutter

Publication type:

Article

Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine.

Published in:

Clinical Pharmacology & Therapeutics, 2008, v. 84, n. 5, p. 595, doi. 10.1038/clpt.2008.143

By:

Malik, M;
Andreas, J-O;
Hnatkova, K;
Hoeckendorff, J;
Cawello, W;
Middle, M;
Horstmann, R;
Braun, M

Publication type:

Article

In This Issue.

Published in:: Clinical Pharmacology & Therapeutics, 2008, v. 84, n. 5, p. 531, doi. 10.1038/clpt.2008.196
Publication type:: Article

Correction to: Effectiveness of Rotigotine plus intensive and goal‑based rehabilitation versus Rotigotine alone in “de‑novo” Parkinsonian subjects: a randomized controlled trial with 18‑month follow‑up.

Published in:

2018

By:

Ferrazzoli, D.;
Ortelli, P.;
Riboldazzi, G.;
Maestri, R.;
Frazzitta, G.

Publication type:

Correction Notice

Correction to: Efficacy and safety of rotigotine in elderly patients with Parkinson’s disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials.

Published in:

2018

By:

Nomoto, Masahiro;
Iwaki, Hirotaka;
Kondo, Hiroyuki;
Sakurai, Masaya

Publication type:

Correction Notice

Efficacy and safety of rotigotine in elderly patients with Parkinson’s disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials.

Published in:

Journal of Neurology, 2018, v. 265, n. 2, p. 253, doi. 10.1007/s00415-017-8671-0

By:

Nomoto, Masahiro;
Iwaki, Hirotaka;
Kondo, Hiroyuki;
Sakurai, Masaya

Publication type:

Article

Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.

Published in:

Journal of Neurology, 2015, v. 262, n. 11, p. 2539, doi. 10.1007/s00415-015-7883-4

By:

Serrao, Mariano;
Ranavolo, Alberto;
Conte, Carmela;
Davassi, Chiara;
Mari, Silvia;
Fasano, Alfonso;
Chini, Giorgia;
Coppola, Gianluca;
Draicchio, Francesco;
Pierelli, Francesco

Publication type:

Article

Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial.

Published in:

Journal of Neurology, 2014, v. 261, n. 10, p. 1887, doi. 10.1007/s00415-014-7427-3

By:

Nomoto, Masahiro;
Mizuno, Yoshikuni;
Kondo, Tomoyoshi;
Hasegawa, Kazuko;
Murata, Miho;
Takeuchi, Masahiro;
Ikeda, Junji;
Tomida, Takayuki;
Hattori, Nobutaka

Publication type:

Article

Variant in the 3′ region of SNCA associated with Parkinson's disease and serum α-synuclein levels.

Published in:

Journal of Neurology, 2012, v. 259, n. 3, p. 497, doi. 10.1007/s00415-011-6209-4

By:

Hu, Yacen;
Tang, Beisha;
Guo, Jifeng;
Wu, Xintian;
Sun, Qiying;
Shi, Changhe;
Hu, Liang;
Wang, Chunyu;
Wang, Lei;
Tan, Liming;
Shen, Lu;
Yan, Xinxiang;
Zhang, Hainan

Publication type:

Article

Is there a difference in gastric emptying between Parkinson’s disease patients under long-term l-dopa therapy with and without motor fluctuations? An analysis using the <sup>13</sup>C-acetate breath test.

Published in:

Journal of Neurology, 2009, v. 256, n. 12, p. 1972, doi. 10.1007/s00415-009-5220-5

By:

Tanaka, Yuji;
Kato, Tomohiro;
Nishida, Hiroshi;
Araki, Hiroshi;
Murase, Masahiko;
Nagaki, Masahito;
Moriwaki, Hisataka;
Inuzuka, Takashi

Publication type:

Article

Parkinson’s disease I: glucocerebrosidase mutations, family history of melanoma and questionable effects of rasagiline.

Published in:

Journal of Neurology, 2009, v. 256, n. 12, p. 2111, doi. 10.1007/s00415-009-5383-0

By:

Strupp, Michael

Publication type:

Article

Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.

Published in:

2017

By:

Geyer, James;
Bogan, Richard

Publication type:

journal article

Contextual Interference Can Facilitate Motor Learning in Older Adults and in Individuals With Parkinson's Disease.

Published in:

2016

By:

Sidaway, Ben;
Ala, Bradley;
Baughman, Katherine;
Glidden, Joshua;
Cowie, Stephanie;
Peabody, Ashley;
Roundy, Darren;
Spaulding, Jennie;
Stephens, Rebecca;
Wright, David L.

Publication type:

journal article

Randomized, double-blind, crossover study of the adhesiveness of two formulations of rotigotine transdermal patch in patients with Parkinson's disease.

Published in:

2018

By:

Elshoff, Jan-Peer;
Bauer, Lars;
Goldammer, Nadine;
Oortgiesen, Marga;
Pesch, Hanna;
Timmermann, Lars

Publication type:

journal article

Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study.

Published in:

2016

By:

Garcia-Borreguero, Diego;
Allen, Richard;
Hudson, John;
Dohin, Elisabeth;
Grieger, Frank;
Moran, Kimberly;
Schollmayer, Erwin;
Smit, René;
Winkelman, John;
Smit, René

Publication type:

journal article

Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study.

Published in:

Current Medical Research & Opinion, 2015, v. 31, n. 5, p. 967, doi. 10.1185/03007995.2015.1030376

By:

Sieb, Jörn Peter;
Themann, Peter;
Warnecke, Tobias;
Lauterbach, Thomas;
Berkels, Reinhard;
Grieger, Frank;
Lorenzl, Stefan

Publication type:

Article

Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations.

Published in:

Current Medical Research & Opinion, 2013, v. 29, n. 12, p. 1657, doi. 10.1185/03007995.2013.841666

By:

Elshoff, Jan-Peer;
Timmermann, Lars;
Schmid, Miriam;
Arth, Christoph;
Komenda, Michael;
Brunnert, Marcus;
Bauer, Lars

Publication type:

Article

Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review.

Published in:

CNS Neuroscience & Therapeutics, 2009, v. 15, n. 2, p. 157, doi. 10.1111/j.1755-5949.2008.00064.x

By:

Jesse, Sarah;
Steinacker, Petra;
Lehnert, Stefan;
Gillardon, Frank;
Hengerer, Bastian;
Otto, Markus

Publication type:

Article